Upon completion of this activity learners should be able to: -Understand the conceptual framework by which abnormal trophoblastic proliferations are classified. With this framework, learners will develop strategies to classify clinical cases more accurately and efficiently in the WHO schema. -Understand the developmental cell biology of trophoblasts. With this cell biological context, learners will be able to apply immunohistochemical analysis such as p63, CD146 and p57 immunostains as they phenotype abnormal trophoblast proliferations more confidently. -Explore the genetic mechanisms driving gestation trophoblastic disease and neoplasia. Leveraging these genetics insights will provide learners the ability to decide when genetic analysis of ploidy and parental origin is appropriate for diagnosis of trophoblastic disease. -Familiarize the learner with rare variants and mimics of gestational trophoblastic disease, so that they can more readily recognize important pitfalls like twin and chimeric/mosaic moles.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Address:
- 5727 Baker Way NW Suite 200
Pricing
CME included with membership
| Non-Member | $495 |
| Member | $395 |
| Trainee & Pathology Assistant | $100 |
Collected from the provider’s public pages · source
Specialties served/covered
- No reviews yet. Be the first to share yours.



